InMode Ltd., a leading global provider of innovative medical technologies, is set to present at two upcoming investor conferences in August. These events will provide an opportunity for the company to showcase its cutting-edge products and advancements in the field.
First on the agenda is the 9th Annual Needham Virtual MedTech & Diagnostics Conference, scheduled for Monday, Aug. 12. InMode’s Chief Executive Officer, Moshe Mizrahy, and Chief Financial Officer, Yair Malca, will participate in virtual one-on-one meetings. This format allows for personalized interactions and in-depth discussions about the company’s offerings.
Following that, InMode will be attending the Canaccord 44th Annual Global Growth Conference on Wednesday, Aug. 14. Yair Malca, the company’s CFO, will be presenting in an in-person fireside chat moderated by Caitlin Cronin, Director of MedTech Equity Research. This session will be complemented by additional meetings to further engage with investors.
InMode’s commitment to innovation is evident in its development, manufacturing, and marketing of devices that utilize novel radiofrequency (RF) technology. The company aims to enable new emerging surgical procedures while enhancing existing treatments. Its comprehensive line of products spans various medical categories, including plastic surgery, gynecology, dermatology, otolaryngology, and ophthalmology.
For more information about InMode and its wide array of medical technologies, interested parties can visit the company’s official website at www.inmodemd.com. Investors and other stakeholders can also reach out to Miri Segal-Scharia, the Investor Relations Contact at MS-IR LLC, via email at ir@inmodemd.com or by phone at 917-607-8654.
InMode’s participation in these investor conferences highlights its dedication to advancing medical technologies and its commitment to fostering relationships with investors and industry professionals. With its innovative solutions, the company continues to make significant contributions to the field of healthcare.